These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Treatment of post-electroconvulsive therapy delirium and agitation with donepezil. Logan CJ; Stewart JT J ECT; 2007 Mar; 23(1):28-9. PubMed ID: 17435571 [TBL] [Abstract][Full Text] [Related]
44. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia. Alwahhabi FK J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444 [TBL] [Abstract][Full Text] [Related]
45. Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules. Prescrire Int; 2009 Feb; 18(99):19. PubMed ID: 19391277 [No Abstract] [Full Text] [Related]
46. [Hallucinations associated to treatment with rivastigmine in two patients with diffuse Lewy body disease]. Alonso-Navarro H; Jiménez-Jiménez FJ Rev Neurol; 2007 May 1-15; 44(9):575-6. PubMed ID: 17492618 [No Abstract] [Full Text] [Related]
47. Effects of rivastigmine in a case of residual schizophrenia. Raguraman J; Sagar JV; Chandrasekaran R Can J Psychiatry; 2005 Mar; 50(4):243-4. PubMed ID: 15898469 [No Abstract] [Full Text] [Related]
48. Rivastigmine in the treatment of postoperative delirium: a pilot clinical trial. Zaslavsky A; Haile M; Kline R; Iospa A; Frempong-Boadu A; Bekker A Int J Geriatr Psychiatry; 2012 Sep; 27(9):986-8. PubMed ID: 22886871 [No Abstract] [Full Text] [Related]
56. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study. Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475 [No Abstract] [Full Text] [Related]
57. Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia. Bosboom JL; Stoffers D; Stam CJ; Berendse HW; Wolters ECh Clin Neurophysiol; 2009 May; 120(5):910-5. PubMed ID: 19386543 [TBL] [Abstract][Full Text] [Related]
58. Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors. Caffarra P; Vezzadini G; Copelli S; Dieci F; Messa G; Nonis E; Venneri A Acta Biomed; 2007; 78(1):16-21. PubMed ID: 17687812 [TBL] [Abstract][Full Text] [Related]
59. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease. Grossberg GT Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903 [TBL] [Abstract][Full Text] [Related]
60. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you! Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]